{
    "clinical_study": {
        "@rank": "79130", 
        "brief_summary": {
            "textblock": "This study involves sampling blood from both normal volunteers and patients with diseases\n      known or suspected to involve body chemicals called catecholamines.  The blood will be used\n      to establish normal values for plasma levels of catecholamines and related neurochemicals;\n      to test for abnormal neurochemical patterns in patients; and to establish a \"bank\" of DNA\n      from normal volunteers and from patients to be used in future studies about possible\n      alterations of catecholamine-related genes.\n\n      Study participants will report to NIH after fasting overnight except for water or\n      noncaloric, noncaffeinated beverages.  They must not have taken Tylenol for at least 5 days.\n      Blood will then be drawn.  DNA will be extracted and stored in the freezer for future\n      studies."
        }, 
        "brief_title": "Blood Sampling for Neurochemical and Genetic Testing", 
        "completion_date": "March 2004", 
        "condition": [
            "Autonomic Nervous System Disease", 
            "Healthy", 
            "Hypertension", 
            "Pheochromocytoma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Autonomic Nervous System Diseases", 
                "Primary Dysautonomias", 
                "Hypertension", 
                "Nervous System Diseases", 
                "Pheochromocytoma"
            ]
        }, 
        "detailed_description": {
            "textblock": "This project is to allow blood sampling from normal volunteers and patients with\n      dysautonomia, pheochromocytoma, hypertension, or neurogenetic diseases involving\n      catecholaminergic systems.  The blood is used to establish normal values for plasma levels\n      of catechols and related neurochemicals; test for abnormal neurochemical patterns in\n      patients; and establish a \"bank\" of DNA samples from normal volunteers and from patients, to\n      be used in future studies about mutations or polymorphisms of catecholamine-related genes."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "INCLUSION CRITERIA:\n\n        The subjects are healthy normal volunteers or patients with dysautonomia,\n        pheochromocytoma, hypertension, or neurogenetic diseases involving catecholaminergic\n        systems.  Children of any age above 4 years may participate.  In the case of minors,\n        consent is obtained from an adult who is legally responsible for the subject.\n\n        EXCLUSION CRITERIA:\n\n        Subjects in whom anatomic or technical factors preclude insertion of an arm intravenous\n        (i.v.) catheter are excluded.  Normal volunteers taking any prescribed medication are\n        excluded.  Normal volunteers who smoke cigarettes or consume alcohol daily are excluded."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": "500", 
        "firstreceived_date": "November 3, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00001147", 
            "org_study_id": "000008", 
            "secondary_id": "00-N-0008"
        }, 
        "keyword": [
            "Dopamine", 
            "Metanephrine", 
            "Norepinephrine", 
            "Epinephrine", 
            "Catecholamines", 
            "Tyrosine Hydroxylase", 
            "Monoamine Oxidase", 
            "Phenosulfotransferase", 
            "Sympathetic Nervous System", 
            "Normetanephrine"
        ], 
        "lastchanged_date": "March 3, 2008", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bethesda", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "20892"
                }, 
                "name": "National Institute of Neurological Disorders and Stroke (NINDS)"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Blood Sampling for Neurochemical and Genetic Testing", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "reference": {
            "PMID": "8863481", 
            "citation": "Goldstein DS, Lenders JW, Kaler SG, Eisenhofer G. Catecholamine phenotyping: clues to the diagnosis, treatment, and pathophysiology of neurogenetic disorders. J Neurochem. 1996 Nov;67(5):1781-90. Review."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00001147"
        }, 
        "source": "National Institutes of Health Clinical Center (CC)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute of Neurological Disorders and Stroke (NINDS)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "October 1999", 
        "study_design": "N/A", 
        "study_type": "Observational", 
        "verification_date": "March 2004"
    }, 
    "geocoordinates": {
        "National Institute of Neurological Disorders and Stroke (NINDS)": "38.985 -77.095"
    }
}